Johnson & Johnson (J&J) recently shared that its medical technology businesses—including Cerenovus and Biosense Webster, as well as Abiomed, DePuy Synthes, and Ethicon—will now go by the name ‘Johnson & Johnson MedTech’. This move “underscores J&J’s leadership in medical technology with a focus on cardiovascular, orthopaedic, surgery and vision solutions”, according to a company press release, […] The post Cerenovus and Biosense Webster among brands newly incorporated into Johnson & Johnson MedTech appeared first on Cardiovascular News .